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THE authors have previously shown that epithelioid cells
isolated from mice secrete a factor, called macrophage
deactivating factor (MDF), that promptly deactivates
superoxide release by activated macrophages and neu-
trophils. In this paper some biological properties of a
polyclonal rat antiserum directed to MDF and other
substances secreted by these cells are described. The
immunoglobulin fraction of this antiserum reacted, by
immunocytochemical methods, with epitopes in the cell
membrane of macrophages adherent to coverslips sub-
cutaneously implanted for 14 days; but not for 5 days. It
also reacted with antigens within and outside cells in
BCG-induced granulomas. This antiserum blocked com-
pletely the macrophage deactivating activity of epithelioid
cell culture supernatants. Anti-IL-10 monoclonal anti-
body, did not block MDF activity. The administration of
the immunoglobulin fraction from immunized rats to C
deficient mice bearing BCG-induced granulomatas in the
footpad, significantly reduced the size of the lesions. A
marked necrosis of inflammatory cells and mononuclear
cells phagocyting debris of necrotic cells were observed
in these lesions.
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Introduction
Epithelioid cells are characteristic cells of
granulomatous inflammation. Under a granuloma-
togenic stimulus, monocytes emigrate to tissues,
become activated macrophages and differentiate or
modulate into pre-epithelioid and epithelioid
cells.
1-3 The role played by these cells in the
maintenance and fate of this type of chronic
inflammatory lesion is almost unknown. Epithelioid
cells experimentally induced in mice are non-
phagocytic and do not express Fc, C3b and
nonspecific surface receptors.
4 The lack of receptor
expression in these cells is not a permanent
phenomenon since they can be re-expressed when
they are cultured in levamisole containing medium,
It has been suggested that secretion is the main
function of epithelioid cells. 6’7 The secretory
property of experimentally induced pre-epithelioid
and epithelioid cells was first demonstrated by
Camarero et al. s These cells secrete a factor named
macrophage deactivating factor (MDF) which
switches off: superoxide anion release by activated
macrophages and neutrophils. This factor was
characterized as a heat stable, trypsin sensitive
11 kDa protein that interferes with membrane
oxidase function of leukocytes.
9 Based on the in vitro
properties of this factor, it was hypothesized that
by deactivating newly arrived macrophages, MDF
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might play a fundamental role in the persistence of
granulomatous lesions.1
In an attempt to further understand the role
played by MDF and other epithelioid cell secreted
substances on the maintenance and fate of infectious
granulomata in vivo, a polyclonal antiserum directed
to antigens secreted by these cells was made and its
effects on the evolution of lesions induced by
bacillus Clamette-Gu&rin (BCG) was investigated.
Materials and Methods
Animals: Outbred mice from the Swiss strain or Cs
deficient mice from the A/J strain were used for the
production of inflammatory cells. Male rats from
the Wistar strain were used for intrasplenic
immunization.
Inqammatory cells" Inflammatory cells were obtained
by insertion of 12 mm round glass coverslips into
the subcutaneous tissue of mice1 and removed 5
and 14 days after implantation.
Antigens" Epithelioid cell secreted substances
(ECSS), containing MDF, were obtained as
follows" coverslips were removed 14 days after
implantation and kept in a 2 ml cuvette for 30 min,
in phosphate buffered saline supplemented with
100 mM/ml of glucose, Ca2+ and Mg
2+ (PBS-G)
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pH 7.2. The cuvette was built with neutral plastic
and silicon sealer. Internal slits were made in the
lateral walls to hold up to 15 coverslips in a vertical
position. These conditioned media (CM) were
pooled, filtered in a 0.2/m Millipore filter and
stored at -20C. The CM were 10 times
concentrated (CCM) in an ultrafiltration device
(Amicon) with a cut-off of 10 kDa and stored at
-20C. Concentrated conditioned media were
prepared with coverslips removed after 5 (CCMs)
or 14 (CCM14) days of inflammation.
Immunization schedule: Rats were immunized by
intrasplenic inoculation12 of 0.1 ml of CCM14. One
week after intrasplenic injection, the animals were
injected i.v. four times--1 week apart from each
inoculation--with 1 ml of CM. One week after the
last injection the animals, under ether anaesthesia,
were bled by intracardiac puncture, the serum
immunoglobulins purified by ammonium sulphate
precipitation and concentrated twice (50 mg pro-
tein/ml) by dialysis against PBS. Immunoglobulins
from normal rat serum were also prepared and
concentrated as above.
Immunocytochemistry: Immunoglobulins from normal
or immunized rats, were used to detect antigens in
cells adherent to coverslips removed after 5 or 14
days. Cryostat sections of BCG induced lesions in
the hind footpad of mice were also used. These
preparations were fixed in cold methanol or acetone
and submitted to immunocytochemical reactions
using rabbit anti-IgG antiserum (Sigma). Controls
included omission of the primary antibody and the
use of irrelevant antibodies of the same IgG
subclass on sections for the same period of
incubations. Before immunostaining, sections were
hydrated in but:fer PBS (pH 7.4) and sequentially
incubated with primary antibody, biotinilated goat
anti-rat IgG (Vector, Burlingame, CA), followed
by streptavidin-biotin conjugated to peroxidase
(Amersham, UK) for 30 min, with 10 min PBS
washes between each incubation. The reaction was
developed with aminoethyl carbazole chromogen in
the presence of hydrogen peroxide, counter-stained
with Mayer’s haematoxylin and mounted in
glycerin-gelatin.
Injtuence of ECSS and anti-ECSS on superoxide anion
liberation by mouse activated macrophages: Mice were
inoculated i.p. with 5 x 106 viable BCG. Seven
days later, macrophages were harvested by washing
the peritoneal cavity of the animals with 3 ml of
PBS. The cell suspension was washed twice in cold
PBS before starting the assay. Cells were
resuspended to achieve the concentration of
4 106 cells/ml in PBS-G. After centrifugation,
cell pellets were resuspended, distributed into
plastic tubes (0.5 ml/tube, 2 106 cells), the cells
recentrifuged and resuspended in the following
solutions: F-c plus 250 #1 of PBS-G; F-c plus 200 #1
of PBS-G and 50 #1 of phorbol miristate acetate
1 ng/ml (PMA); F-c 200 1 of PBS-G, 50/1 of
PMA, 125 #1 of PBS-G, 125 #1 CCM14; F-c 200
of PBS-G, 50/1 of PMA and 125/,1 of immuno-
globulin (1:50) from immunized rats, 125 #1 of
CCM14; F-c 200/*1 of PBS-G, 50/1 of PMA and
125 #1 of immunoglobulin (1:50) from normal rat
serum, 125/1 of CCM14. The following solution
was taken as a blank: 250/1 of F-c, 4mg in
PBS-G (F-c) plus 250 #1 of PBS-G without cells.
Immunoglobulins from normal and immunized
rats (1:50) were mixed with equal volume of
CCM14 incubated for 1 h at 37C and further
incubated for 40 min with activated macrophages
prior to addition to the reaction solutions.
Four wells of a 96-well plate were filled with 100/1
of each of these cell suspensions and kept at 37C
for 1 h before reading in an ELISA reader
(Dynatech MR 5000) with a 550 nm filter.
13
Inquence of anti-IL-lO on MDF activity: Anti-IL-10
monoclonal antibody produced by the SXC-2
hybridoma donated by DNAX Research Institute
of Molecular and Cellular Biology Inc., Palo Alto,
CA, USA, was used. Anti-IL-10 (10/g of protein
per ml) was added to CCM14 at dierent
concentrations and incubated for 1 h at 37C. This
solution was tested for MDF activity as above.
Immunoglobulin administration: Mice injected with BCG
(5 x 106 viable particles) in the hind footpad 14
days before, received four daily i.p. injections of
0.2 ml (10 mg protein) of concentrated immuno-
globulins obtained from normal or immunized rats.
The footpad thickness increase was daily measured
as described above. Seven days after the first
injection the animals were sacrificed, the BCG
induced lesions removed, fixed in Bouin’s fixative
and processed for histological examination.
Statistical analysis: Means of results were compared
by Student’s t-test or two-way ANOVA followed
by the Duncan test. A probability level of less than
0.05 was taken as significant.
Results
Anti-MDF antibodies are present in anti-ECSS antiserum:
The addition of CCM plus PMA to a suspension of
BCG activated macrophages almost completely
inhibited superoxide release by these cells. Con-
versely, the addition of immunoglobulins from
immunized but not from normal rats to the system,
restored the ability of activated macrophages to
release superoxide anions, demonstrating that
anti-MDF antibodies are present in immune serum
(Fig. 1).
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FIG. 1. The CM14 blocks the liberation of superoxide anions by peritoneal
mouse BCG-activated macrophages in vitro. The addition of anti-ECSS
antibodies (Ab) reverts this activity and antibodies from normal rat serum
(Ns) have no effect.
MDF vs IL-IO" The addition of anti-IL-10
monoclonal antibody to CCM did not inhibit 07
production by activated macrophages in vitro.
Immunocytochemistry: When anti-ECSS immunoglobu-
lins were used as primary antibody (1:5 dilution),
a strong staining was detected delimitating most of
the cells obtained after 14 days of coverslip
implantation (Fig. 2). The reaction was negative
using cells obtained after 5 days of coverslip
implantation. Negative results were found in the
following controls: cells from 14 days of coverslip
implantation submitted to the reaction using PBS
or BSA instead of primary antiserum; using normal
rat serum (1:200) instead of primary antiserum;
omission of the secondary antibody incubation;
FIG. 2. Antibodies anti-ECSS detect epitopes in cells on the surface of
coverslips removed after 14, but not after 5 days (not shown) of
implantation in the subcutaneous tissue of mice. The antibodies are
revealed by immunoperoxidase technique (100 x ).
FIG. 3. Using the same technique as in Fig. 2 antibodies anti-ECSS detect
epitopes in cells of the central area of BCG-induced granuloma evoked
by the bacteria inoculation 14 days before (100 ).
omission of the amplification complex and reaction
only with the substrates.
When cryostat sections of 14 day BCG induced
granulomatas were tested as above, the reaction was
positive within and outside cells mainly in the
central area of the granulomatas (Fig. 3).
Anti-ECSS immunoglobulins influence the evolution of BCG
induced granulomatas: The i.p. administration of 5 mg
of purified immunoglobulins from immunized rats,
for 4 consecutive days, significantly reduced the size
of granulomatas induced by BCG injection 14 days
before in the footpad of the animals. As shown in
Fig. 4, the administration of immunoglobulins from
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FIG. 41 The intraperitoneal injection, for four consecutive days, of
anti-ECSS (1-1) to mice bearing BCG-induced granulomas in the footpad
for 14 days, significantly reduced the size of the lesions after the third day
of treatment (p < 0.05).
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FIG. 5. Histopathology of typical arrangement of inflammatory macro-
phages in a granuloma induced by BCG inoculation 21 days before. (H&E
stain 100 x ).
Typical BCG induced lesions were observed in
the footpad of mice treated with normal rat
immunoglobulins (Fig. 5). The treatment of mice
with immunoglobulins from immunized rats,
induced disuse necrosis of mononuclear cells in the
granulomas, characterized by loss of cell sharp and
nuclear picnosis. Phagocytosis of picnotic nuclei
and cell debris by monocytoid macrophages (newly
arrived cells) were observed (Fig. 6). This
phenomenon was clearly characterized in five out
of six examined lesions.
FIG. 6. Necrosis of inflammatory macrophages and phagocytosis of
picnotic nuclei by newly arrived phagocytic mononuclear cells in
granulomatous lesion induced by BCG inoculation 21 days before. The
animals were treated for four consecutive days by intraperitoneal injection
of immunoglobulins isolated from rats immunized with ECSS. (H&E stain
lOOx).
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Discussion
Mouse epithelioid macrophages are poor phago-
cytic cells;4’14 they lose the capacity to release
superoxide anion but secrete, among other not well
characterized substances, an 11 kDa protein that
deactivates activated macrophages and neutro-
phils.
8,9
The origin of epithelioid cell secreted antigens
was detected by immunocytochemical methods in
cells removed after 14 but not after 5 days of
coverslip implantation. The results show that
although polyclonal, the antiserum raised against
ECSS is able to discriminate epithelioid from other
types of inflammatory macrophages. Further, the
detection of similar epitopes in BCG induced
granulomatas, demonstrate that these antigens are
not restricted to the coverslip model but also are
synthesized by cells in an experimental infectious
lesion.
The detection of these antigens in cells on
the coverslip or in cells from BCG induced
granulomatas does not yield information concern-
ing the possible role these substances play on the
evolution, persistence and fate of the lesions. The
significant decrease in the volume of the BCG
induced granulomas, the marked necrosis of
inflammatory cells and monocytoid cell infiltration
of the lesions in animals injected with immuno-
globulins from immunized rats are clear evidence
that the blockage of antigens secreted by epithelioid
cells drastically modifies the fate of this type of
inflammatory process. The mechanisms by which
these immunoglobulins induced this phenomenon
was not determined. Nevertheless, Henriques et al.
is
have shown that 90% of inflammatory macrophages
collected after 24 h of carrageen inoculation into the
pleural cavity of mice, immunostain with the
anti-ECSS antibodies. Yet, they have shown that
these cells also secrete a factor which deactivates
activated macrophages as does MDF. A polyclonal
antibody directed to antigens secreted by macro-
phages from 24 h pleural carrageen induced lesions
not only immunostained these cells but also cells
on the surface of coverslips removed after 14 days,
but not from 5 days after implantation in the
subcutaneous tissue of mice. The inoculation of this
antibody followed by carrageen injection into the
pleural cavity of mice, completely abrogated the
onset of cells expressing antigens revealed by
antibodies anti-ECSS. These results provide evi-
dence to support the suggestion that, similar to the
necrosis of inflammatory cells observed in BCG
induced granulomatas of mice treated with anti-
ECSS, antibodies directed to secretory products of
macrophages from carrageen induced pleurisy also
kill or prevent the onset of cells which secrete
MDF. In these experiments, after antibodyEpithelioid cell secreted substances
treatment, almost all mononuclear adherent cells
present in the pleural cavity were of the Mac1 +
phenotype or activated macrophages. This indirect
evidence supports the hypothesis that antibodies
anti-ECSS not only block MDF activity, as shown
in vitro, but also may delete cells carrying antigens
similar to those secreted by epithelioid cells.
The observed effect of the polyclonal antibodies
directed to ECSS might be due to the inhibition
of known mediators of granuloma formation
and persistence. Kindler et al.
16 demonstrated
that anti-TNF antibodies block the onset of
granulomatas induced by BCG inoculation in mice.
Based on their results, it is likely that anti-ECSS
polyclonal antibody might have anti-TNF activity.
This possibility was discarded since anti-CCM14
antibodies do not block TNF necrotic activity on
the L-929 cell line. TNF activity was also not
detected in Gem14 (data not shown).
Among other factors with MDF activity,
17-22 it
has been demonstrated that IL-10, similarly to
MDF, also deactivates macrophages in vitro in a
short period of contact
23 and that anti-IL-10
monoclonal antibody administration interferes with
the outcome of Trypanosoma cruzi infection in
mice.24 To rule out the presence of IL-10 in CCM14
a monoclonal antibody anti-IL-10 was added to
GEM14 and the deactivating property of this
supernatant tested. The monoclonal antibody did
not block the inhibitory activity of MDF as
measured by superoxide anion release by BCG
activated macrophages, thus indicating that MDF
do not share epitopes similar to those of IL-10.
In conclusion, the marked effect of immunoglo-
bulins isolated frcm anti-ECSS serum on the size
and morphology of ,BCG induced granulomatas,
demonstrates that substances secreted by epithelioid
cells do play a role in the maintenance and fate of
the lesion. As previously hypothesized
1 epithelioid
cell secretory products such as MDF, are
determinants of granuloma persistence by deactiva-
ting T-cell activated macrophages that migrate to
maintain the cell turnover of the lesion and
eliminate parasites.
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